رجوع
67
نطاق اليوم
KWD 92.19
KWD 92.19
نطاق 52 أسبوعًا
KWD 80.91
KWD 110.40
حجم التداول
3,750
متوسط 50 يوم / 200 يوم
KWD 87.88
/
KWD 92.53
الإغلاق السابق
KWD 92.19
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 21.3 | 0.4 |
| P/B | 6.3 | 2.9 |
| ROE % | 32.6 | 3.7 |
| Net Margin % | 33.9 | 3.8 |
| Rev Growth 5Y % | -0.9 | 10.0 |
| D/E | 0.2 | 0.2 |
النقاط الرئيسية
Revenue declined -0.94% annually over 5 years
Earnings grew 186.92% over the past year
ROE of 32.58% indicates high profitability
Net margin of 33.87% shows strong profitability
Debt/Equity of 0.20 — conservative balance sheet
Generating 43.73M in free cash flow
النمو
Revenue Growth (5Y)
-0.94%
Revenue (1Y)26.57%
Earnings (1Y)186.92%
FCF Growth (3Y)N/A
الجودة
Return on Equity
32.58%
ROIC9.99%
Net Margin33.87%
Op. Margin18.19%
الأمان
Debt / Equity
0.20
Current Ratio3.02
Interest Coverage37.85
التقييم
P/E Ratio
21.31
P/B Ratio6.34
EV/EBITDA40.48
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 26.57% | Revenue Growth (3Y) | 18.29% |
| Earnings Growth (1Y) | 186.92% | Earnings Growth (3Y) | 711.95% |
| Revenue Growth (5Y) | -0.94% | Earnings Growth (5Y) | -5.21% |
| Profitability | |||
| Revenue (TTM) | 221.31M | Net Income (TTM) | 74.96M |
| ROE | 32.58% | ROA | 18.98% |
| Gross Margin | 94.46% | Operating Margin | 18.19% |
| Net Margin | 33.87% | Free Cash Flow (TTM) | 43.73M |
| ROIC | 9.99% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.20 | Current Ratio | 3.02 |
| Interest Coverage | 37.85 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 21.31 | P/B Ratio | 6.34 |
| P/S Ratio | 7.22 | PEG Ratio | 0.09 |
| EV/EBITDA | 40.48 | Dividend Yield | 0.01% |
| Market Cap | 1.60B | Enterprise Value | 1.63B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 221.31M | 174.86M | 158.15M | 196.34M | 229.83M |
| Net Income | 74.96M | 26.13M | 1.14M | 49.36M | 92.86M |
| EPS (Diluted) | 4.36 | 1.49 | 0.06 | 2.73 | 5.13 |
| Gross Profit | 209.05M | 166.67M | 148.54M | 182.70M | 213.39M |
| Operating Income | 40.26M | 6.47M | -3.83M | 44.07M | 92.45M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 394.93M | 349.64M | 340.52M | 393.26M | 368.39M |
| Total Liabilities | 142.48M | 141.29M | 147.08M | 170.30M | 190.47M |
| Shareholders' Equity | 251.74M | 208.36M | 193.44M | 222.96M | 177.92M |
| Total Debt | 50.53M | 51.08M | 43.67M | 42.63M | 49.33M |
| Cash & Equivalents | 17.81M | 63.24M | 60.02M | 149.81M | 113.35M |
| Current Assets | 283.31M | 250.25M | 252.60M | 275.18M | 295.23M |
| Current Liabilities | 93.84M | 82.69M | 95.89M | 97.32M | 86.35M |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#58 of 326
النشاط الأخير
دخل
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026